MyAverix Finance
US · Healthcare
Towa Pharmaceutical Co. Ltd (TWAPF)
Drug Manufacturers - Specialty & Generic
Towa Pharmaceutical Co. Ltd (TWAPF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $1.25B, P/E ratio is 9.45, net margin is 8.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for TWAPF
Towa Pharmaceutical Co. Ltd (TWAPF) — FAQ
What is Towa Pharmaceutical Co. Ltd's market cap?
Towa Pharmaceutical Co. Ltd (TWAPF) has a reported market cap of $1.25B (data as of 2026-03-30).
What is TWAPF's P/E ratio?
The price-to-earnings (P/E) ratio for Towa Pharmaceutical Co. Ltd (TWAPF) is 9.45 (data as of 2026-03-30).
Does Towa Pharmaceutical Co. Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Towa Pharmaceutical Co. Ltd (TWAPF). Check the MyAverix Finance app for the latest dividend data.
What sector is Towa Pharmaceutical Co. Ltd in?
Towa Pharmaceutical Co. Ltd (TWAPF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is TWAPF listed on?
TWAPF is listed on US.
What is Towa Pharmaceutical Co. Ltd's net margin?
Towa Pharmaceutical Co. Ltd (TWAPF) reports a net margin of 8.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.